On Tuesday, October 27, Express Scripts will announce its third-quarter results after the market closes. While shares have pulled back about 7% since it last reported results, the healthcare ...

Express Scripts Holding Co. defeated a bid by retail drugstores to suspend its $29.1 billion purchase of Medco Health Solutions Inc. while a lawsuit challenging the takeover is pending. Express ...

Can the information behind these seven least wasteful states lead investors to ideas for finding luck in the stock market? I think so. While these states fare better in the analysis, every one of them ...

In Express Scripts’ report, watch for how much of its sales come from generic drugs, which are more profitable for the company. As more newly off-patent drugs produce new generics, Express Scripts ...

Express Scripts Holding, a pharmacy benefit manager that negotiates drug prices for many health plans, will launch a formulary with lower list price drugs in an effort to reduce reliance on rebates ...

NEW YORK (AP) -- Shares of Express Scripts Holding Co. fell 12 percent on Tuesday after the pharmacy benefits manager said Wall Street's expectations for its 2013 earnings may be too optimistic. THE ...

Kathleen Mazzarella, chairman, president and CEO of Graybar. Express Scripts Holding Co. has elected Kathleen Mazzarella, chairman, president and CEO of Graybar Electric Co. Inc., to its board.

Total spending on health care in the United States is expected to climb from $3 trillion to over $4 trillion annually by the end of the decade, and while that may mean sales growth for a lot of health ...

(Reuters) - Pharmacy benefit manager Express Scripts Holding Co said the potential risk of liver injury from AbbVie' hepatitis C treatments will not impact the availability of the treatment for ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Of the 100 positions Express Scripts Holding Co. said this ...

(Reuters) - Express Scripts Holding Co, the largest U.S. pharmacy benefit manager, on Friday said it will remove 25 products from its 2015 list of preferred drugs, including anemia treatments Epogen ...